Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 7—July 2009
Dispatch

Lack of Macrolide Resistance in Chlamydia trachomatis after Mass Azithromycin Distributions for Trachoma

Kevin Cyrus Hong, Julius Schachter, Jeanne Moncada, Zhaoxia Zhou, Jenafir House, and Thomas M. LietmanComments to Author 
Author affiliations: University of California, San Francisco, California, USA

Main Article

Table

Antimicrobial drug susceptibilities of Chlamydia trachomatis, Ethiopia*

Treatment status Serotype Azithromycin†
Doxycycline†
MIC MCC MIC MCC
4 biannual A/Har13 0.5 0.5 0.03 0.03
Ba/Apache-2 0.5 0.5 0.03 0.03
Ba/Apache-2 0.5 0.5 0.03 0.06
Ba/Apache-2 0.25 0.5 0.03 0.06
Ba/Apache-2 0.5 0.5 0.03 0.06

Ba/Apache-2
0.5
0.5

0.03
0.03
None A/Har 13 0.5 0.5 0.03 0.03
A/Har 13 0.5 0.5 0.03 0.03
A/Har 13 0.5 1 0.015 0.06
Ba/Apache-2 0.25 0.25 0.03 0.03

*Samples taken in 2006, 18 months after 4 biannual treatments in 2003–2004. MCC, minimum chlamydicidal concentration.
†MIC and MCC values given in μg/mL.

Main Article

Page created: November 08, 2010
Page updated: November 08, 2010
Page reviewed: November 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external